Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PEPCID COMPLETE | Johnson & Johnson | N-020958 OTC | 2000-10-16 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PEPCID AC | Johnson & Johnson | N-020325 OTC | 1995-04-28 | 2 products, RLD |
PEPCID AC | Johnson & Johnson | N-020801 OTC | 2007-12-17 | 1 products, RLD, RS |
PEPCID AC | Johnson & Johnson | N-020902 OTC | 1999-08-05 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUEXIS | Horizon Pharmaceutical | N-022519 RX | 2011-04-23 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
acid controller | ANDA | 2023-10-13 |
acid reducer | ANDA | 2022-04-13 |
acid reducer complete | ANDA | 2022-07-19 |
acid reducer plus antacid | ANDA | 2022-07-19 |
acid relief | ANDA | 2023-10-02 |
basic care acid reducer | ANDA | 2022-04-11 |
basic care dual action complete | ANDA | 2022-07-11 |
basic care famotidine | ANDA | 2020-02-19 |
basic care heartburn prevention | ANDA | 2022-01-05 |
berkley and jensen famotidine | ANDA | 2023-12-22 |
Code | Description |
---|---|
S0028 | Injection, famotidine, 20 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 1 | 7 | 4 | 2 | 5 | 18 |
Peptic ulcer | D010437 | HP_0004398 | K27 | — | — | 1 | 2 | 3 | 6 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 1 | 2 | 2 | 1 | 1 | 5 |
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | 1 | — | 3 |
Heartburn | D006356 | — | R12 | 2 | — | — | 1 | — | 3 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | 2 | — | 2 |
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | — | 2 | — | 2 |
Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | — | 2 | — | 2 |
Stomach ulcer | D013276 | — | K25 | — | — | 1 | 1 | — | 2 |
Infections | D007239 | EFO_0000544 | — | 1 | — | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 2 | — | 1 | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | 1 | — | — | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | 2 | — | — | 2 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 2 | — | — | 2 |
Low back pain | D017116 | HP_0003419 | M54.5 | — | — | 2 | — | — | 2 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | 1 | — | — | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | — | — | 1 | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | — | — | 1 | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | — | 1 | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | 1 | 2 |
Laryngomalacia | D055092 | HP_0001601 | — | 1 | 1 | — | — | 1 | 2 |
Fallopian tube neoplasms | D005185 | — | — | — | 1 | — | — | — | 1 |
Peritoneal neoplasms | D010534 | — | — | — | 1 | — | — | — | 1 |
Brain edema | D001929 | EFO_1000845 | G93.6 | — | 1 | — | — | — | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 1 | — | — | — | 1 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | — | 1 | — | — | — | 1 |
Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | — | 1 | — | — | — | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | — | 1 | — | — | — | 1 |
Dyskinesias | D020820 | HP_0002310 | G24 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 20 | — | — | — | 2 | 22 |
Drug interactions | D004347 | — | — | 2 | — | — | — | — | 2 |
Biological availability | D001682 | — | — | 2 | — | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 2 | — | — | — | — | 2 |
Hairy cell leukemia | D007943 | — | C91.4 | 1 | — | — | — | — | 1 |
Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 1 | — | — | — | — | 1 |
Fibrosis | D005355 | — | — | 1 | — | — | — | — | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | — | — | — | — | 1 |
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 2 | 2 |
Rhytidoplasty | D015361 | — | — | — | — | — | — | 1 | 1 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 1 | 1 |
Cytokine release syndrome | D000080424 | — | D89.83 | — | — | — | — | 1 | 1 |
Vomiting | D014839 | HP_0002013 | R11.1 | — | — | — | — | 1 | 1 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 1 | 1 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | — | — | 1 | 1 |
Respiratory sounds | D012135 | HP_0010307 | R06.1 | — | — | — | — | 1 | 1 |
Post-exercise hypotension | D057774 | EFO_1001828 | — | — | — | — | — | 1 | 1 |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 1 | 1 |
Drug common name | Famotidine |
INN | famotidine |
Description | Famotidine, sold under the brand name Pepcid among others, is a histamine H2 receptor antagonist medication that decreases stomach acid production. It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is taken by mouth or by injection into a vein. It begins working within an hour.
|
Classification | Small molecule |
Drug class | H2-receptor antagonists (cimetidine type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1 |
PDB | — |
CAS-ID | 76824-35-6 |
RxCUI | — |
ChEMBL ID | CHEMBL902 |
ChEBI ID | 4975 |
PubChem CID | 5702160 |
DrugBank | DB00927 |
UNII ID | 5QZO15J2Z8 (ChemIDplus, GSRS) |